Valneva SE VALN
NASDAQ VALN
$6.89 -0.17 (-2.41%)
At close: Sep 4, 2026 · 4:00 PM EDT

Valneva SE (VALN) Other Working Capital Changes (2021 - 2026)

Valneva SE (VALN) posted Other Working Capital Changes of -$801960.8 for Q1 2026, down 4.57% sequentially from -$766900.1 in Q3 2025, and down 11.3% YoY from -$904125.5 in Q1 2025.

Analysis

Valneva SE (VALN) Other Working Capital Changes (2021 - 2026) Analysis & Trends

Valneva SE has reported Other Working Capital Changes for 6 years, with the latest figure at -$801960.8 in Q1 2026.

  • Quarterly Other Working Capital Changes fell 11.3% year-over-year to -$801960.8 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$3.1 million (down 5.0% YoY) and the FY2024 annual result came in at -$2.9 million, up 13.0% from the prior year.
  • Other Working Capital Changes eased to -$801960.8 in Q1 2026 per VALN's latest filing, from -$766900.1 in the prior quarter.
  • Over five years, Other Working Capital Changes peaked at $1.9 billion in Q3 2023 and troughed at -$1.9 billion in Q2 2023.
  • A 5-year average of -$825700.5 and a median of -$753718.7 in 2022 frame the typical range for Other Working Capital Changes.
  • The widest YoY moves for Other Working Capital Changes: up 292306.32% in 2023, down 255621.4% in 2023.
  • Over 5 years, Other Working Capital Changes stood at -$894756.9 in 2022, then increased by 17.87% to -$734867.0 in 2023, then soared by 110.03% to $73733.1 in 2024, then slumped by 1140.1% to -$766900.1 in 2025, then decreased by 4.57% to -$801960.8 in 2026.
  • According to Business Quant data, Other Working Capital Changes over the past three periods registered -$801960.8, -$766900.1, and -$791239.8 for Q1 2026, Q3 2025, and Q2 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn
5 Revolution Medicines 44.33 Bn 44.33 Bn -
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn
8 Royalty Pharma 28.45 Bn 27.61 Bn -
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn
10 Valneva SE 578.54 Mn 437.28 Mn 1.86 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 5.67 Mn
Jun 30, 2026 5.67 Mn
Mar 31, 2026 20.16 Mn
Mar 31, 2026 20.16 Mn
Dec 31, 2025 -3.55 Mn
Dec 31, 2025 -3.55 Mn
Sep 30, 2025 10.95 Mn
Sep 30, 2025 10.95 Mn
Jun 30, 2025 1.57 Mn
Jun 30, 2025 1.57 Mn
Mar 31, 2025 -9.65 Mn
Mar 31, 2025 -9.65 Mn
Dec 31, 2024 25.31 Mn
Dec 31, 2024 25.31 Mn
Sep 30, 2024 -4.31 Mn
Sep 30, 2024 -4.31 Mn
Jun 30, 2024 -21.79 Mn
Jun 30, 2024 -21.79 Mn
Mar 31, 2024 -11.87 Mn
Mar 31, 2024 -11.87 Mn